Oric Pharmaceuticals Inc. has granted a total of 18,400 non-qualified stock options and 3,000 restricted stock units to a new non-executive employee who joined the company in October 2025. The stock options have an exercise price equal to the closing price of Oric's common stock on the grant date. Twenty-five percent of the stock options will vest on the first anniversary of the grant date, with the remaining shares vesting in equal monthly installments over the following three years. The restricted stock units will vest in three equal annual installments on each anniversary of the grant date.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oric Pharmaceuticals Inc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9569024-en) on November 07, 2025, and is solely responsible for the information contained therein.